These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 19588841

  • 1. [Lymphocyte subpopulations in patients with Yusho].
    Tsuji H.
    Fukuoka Igaku Zasshi; 2009 May; 100(5):131-5. PubMed ID: 19588841
    [Abstract] [Full Text] [Related]

  • 2. [Differential correlation of medical/laboratory examinations with blood levels of polychlorinated biphenyls, polychlorinated quarterphenyls and 2,3,4,7,8-pentachlorodibenzofuran in Yusho patients from 2001 to 2004].
    Kanagawa Y, Matsumoto S, Akahane M, Koike S, Yoshimura T, Uchi H, Furue M, Imamura T.
    Fukuoka Igaku Zasshi; 2009 May; 100(5):166-71. PubMed ID: 19588845
    [Abstract] [Full Text] [Related]

  • 3. [Dioxin concentration in the preserved umbilical cord from Yusho patients].
    Kajiwara J, Todaka T, Hirakawa H, Hori T, Yasutake D, Nakagawa R, Iida T, Nagayama J, Yoshimura T, Furue M.
    Fukuoka Igaku Zasshi; 2009 May; 100(5):179-82. PubMed ID: 19588847
    [Abstract] [Full Text] [Related]

  • 4. Concentrations of polychlorinated biphenyls in blood collected from Yusho patients during medical check-ups performed from 2004 to 2007.
    Todaka T, Hori T, Yasutake D, Yoshitomi H, Hirakawa H, Onozuka D, Kajiwara J, Iida T, Yoshimura T, Furue M.
    Fukuoka Igaku Zasshi; 2009 May; 100(5):156-65. PubMed ID: 19588844
    [Abstract] [Full Text] [Related]

  • 5. [The difference between male and female dioxin concentrations in the blood of Yusho patients].
    Kajiwara J, Todaka T, Hirakawa H, Hori T, Onozuka D, Takao Y, Hirata T, Iida T, Uchi H, Furue M.
    Fukuoka Igaku Zasshi; 2011 Apr; 102(4):140-4. PubMed ID: 21706894
    [Abstract] [Full Text] [Related]

  • 6. [Immune effects of endocrine disruptors].
    Tsuji H.
    Nihon Rinsho; 2000 Dec; 58(12):2533-8. PubMed ID: 11187750
    [Abstract] [Full Text] [Related]

  • 7. [Mitogen-induced lymphocyte transformation in patients with Yusho].
    Tsuji H, Suzuki N, Sakisaka S.
    Fukuoka Igaku Zasshi; 2001 May; 92(5):112-4. PubMed ID: 11452506
    [Abstract] [Full Text] [Related]

  • 8. [Prevalence of atopic dermatitis and serum IgE of Yusho patients].
    Uchi H, Furue M.
    Fukuoka Igaku Zasshi; 2009 May; 100(5):127-30. PubMed ID: 19588840
    [Abstract] [Full Text] [Related]

  • 9. [Impaired mitogen-induced lymphocyte transformation in patients with Yusho].
    Tsuji H, Ito Y.
    Fukuoka Igaku Zasshi; 2011 Apr; 102(4):81-6. PubMed ID: 21706884
    [Abstract] [Full Text] [Related]

  • 10. [Serum immunoglobulin concentrations and autoantibodies in patients with Yusho].
    Tsuji H, Hirahashi T, Ogata H, Fujishima M.
    Fukuoka Igaku Zasshi; 1999 May; 90(5):147-9. PubMed ID: 10396868
    [Abstract] [Full Text] [Related]

  • 11. [Peculiar remaining of some PCB congeners in the patients with Yusho for more than 30 years].
    Masuda Y, Haraguchi K, Kono S.
    Fukuoka Igaku Zasshi; 2003 May; 94(5):136-43. PubMed ID: 12872714
    [Abstract] [Full Text] [Related]

  • 12. Follow-up survey of dioxin concentrations in the blood of Yusho patients in 2002-2003.
    Todaka T, Hirakawa H, Hori T, Tobiishi K, Iida T.
    Fukuoka Igaku Zasshi; 2005 May; 96(5):249-58. PubMed ID: 15997781
    [Abstract] [Full Text] [Related]

  • 13. [Estimated half-life of penta-chlorodibenzofuran (PeCDF) and simulation of PeCDF excretion].
    Akahane M, Matsumoto S, Kanagawa Y, Kajiwara J, Todaka T, Hirakawa H, Koike S, Furue M, Imamura T.
    Fukuoka Igaku Zasshi; 2009 May; 100(5):172-8. PubMed ID: 19588846
    [Abstract] [Full Text] [Related]

  • 14. [Average of the PCDFs value in blood in patients with Yusho in the 2001 to 2003 fiscal year and comparison between the clinical features and PCDFs].
    Kanagawa Y, Matsumoto S, Tajima B, Uenotsuchi T, Shibata S, Furue M, Imamura T.
    Fukuoka Igaku Zasshi; 2007 May; 98(5):129-35. PubMed ID: 17642286
    [Abstract] [Full Text] [Related]

  • 15. [Investigation of PCB pollution evaluation for Yusho victims using their preserved umblical cord].
    Miyata H, Aozasa O, Nakao T, Ohta S.
    Fukuoka Igaku Zasshi; 2009 May; 100(5):183-91. PubMed ID: 19588848
    [Abstract] [Full Text] [Related]

  • 16. [Laboratory findings in patients with Yusho: 26 year follow-up study].
    Tsuji H, Ikeda K, Suzuki N, Fujishima M.
    Fukuoka Igaku Zasshi; 1995 May; 86(5):273-6. PubMed ID: 7628820
    [Abstract] [Full Text] [Related]

  • 17. Excretion of causative PCDFs congeners of Yusho by one year intake of FBRA in patients with Yusho.
    Nagayama J, Hirakawa H, Kajiwara J, Iida T, Todaka T, Uenotsuchi T, Shibata S, Tsuji H, Iwasaki T.
    Fukuoka Igaku Zasshi; 2007 May; 98(5):215-21. PubMed ID: 17642300
    [Abstract] [Full Text] [Related]

  • 18. Dioxin concentration in the blood of patients collected during medical check-up for Yusho in 2004-2005.
    Todaka T, Hirakawa H, Kajiwara J, Hori T, Tobiishi K, Onozuka D, Iida T, Yoshimura T, Furue M.
    Fukuoka Igaku Zasshi; 2007 May; 98(5):222-31. PubMed ID: 17642301
    [Abstract] [Full Text] [Related]

  • 19. [Association between the results of blood test and blood PCB level of chronic Yusho patients twenty five years after the outbreak].
    Tokunaga S, Hirota Y, Kataoka K.
    Fukuoka Igaku Zasshi; 1999 May; 90(5):157-61. PubMed ID: 10396871
    [Abstract] [Full Text] [Related]

  • 20. [Trend of 2,3,4,7,8-PeCDF concentrations in the blood of Yusho patients over four years].
    Takao Y, Onozuka D, Kataoka K, Todaka T, Hirakawa H, Kajiwara J, Yoshimura T.
    Fukuoka Igaku Zasshi; 2007 May; 98(5):149-52. PubMed ID: 17642290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.